{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:22:57Z","timestamp":1782289377537,"version":"3.54.5"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Estimates of the impact of lung cancer screening (LCS) largely rely on the 3.97% lung cancer diagnosis rate (LCDR) from the National Lung Screening Trial.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate the LCDR in clinical LCS and incidental pulmonary nodule (IPN) programs.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This prospective cohort study of a large regional community health care system in the Mississippi Delta included patients who had at least 1 low-dose computed tomography (CT) scan for lung cancer or any CT scan finding an IPN diameter of 30 mm or less and no prior history of lung cancer between January 1, 2015, and June 30, 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Patient surveillance in LCS or IPN programs.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was aggregate LCDRs. Secondary outcomes were relative LCDRs stratified by baseline Lung CT Screening Reporting and Data System (Lung-RADS) score (LCS cohort) or nodule size (IPN cohort). Adjusted hazard ratios (AHRs) were estimated using a Cox proportional hazards model adjusted for age, sex, race, insurance, rurality, comorbidities, personal history of non\u2013lung cancer, and family history of lung cancer.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 40 612 patients, 15 754 were enrolled in the LCS cohort (median [IQR] age, 65 [59-69] years; 7990 male [50.7%]) and 24\u202f858 were enrolled in the IPN cohort (median [IQR] age, 64 [52-74] years; 13 919 female [56.0%]). Among patients in the LCS cohort, 13 517 (85.8%), 994 (6.3%), 559 (3.5%), 284 (1.8%), and 179 (1.1%) had Lung-RADS scores of 1 or 2, 3, 4A, 4B, and 4X, respectively. Among patients in the IPN cohort, 9204 (37.0%) had a baseline nodule diameter of less than 6 mm, 12\u202f872 (51.8%) had a nodule of 6 to 15 mm, 1570 (6.3%) had a nodule of greater than 15 to 20 mm, and 1212 (4.9%) had a nodule of greater than 20 to 30 mm. The cumulative LCDR at 36 months was 3.8% (95% CI, 3.4%-4.1%) and 4.3% (95% CI, 4.1%-4.6%), with a median follow-up of 546 days (IQR, 237-996 days) and 647 days (IQR, 248-1279 days), in the LCS and IPN cohorts, respectively. With Lung-RADS 1 to 2 as the reference, AHRs were 3.38 (95% CI, 2.48-4.62), 7.41 (95% CI, 5.49-49.10), 25.46 (95% CI, 19.36-33.47), and 107.22 (95% CI, 82.76-138.19) for Lung-RADS 3, 4A, 4B, and 4X, respectively, and 0.59 (95% CI, 0.44-0.79), 2.66 (95% CI, 2.23-3.18), 9.93 (95% CI, 8.06-12.22), and 15.65 (95% CI, 12.67-19.32) for nodules less than 6 mm, 6 to 15 mm, greater than 15 to 20 mm, and greater than 20 to 30 mm in the IPN cohort. Five-year overall survival was 58% (95% CI, 52%-65%) and 46% (95% CI, 43%-50%) in the LCS vs IPN cohorts.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of LCS and IPN program patients, approximately 4% were diagnosed with lung cancer over less than half the duration of the NLST cohort, suggesting a greater population-level LCDR through these screening programs than estimated by clinical trial data.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.3171","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:30:28Z","timestamp":1776094228000},"page":"e263171","source":"Crossref","is-referenced-by-count":1,"title":["Lung Cancer Diagnosis Rates in Early Detection Programs in the Mississippi Delta"],"prefix":"10.1001","volume":"9","author":[{"given":"Wei","family":"Liao","sequence":"first","affiliation":[{"name":"Thoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tye","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Goss","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Fehnel","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Ray","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond U.","family":"Osarogiagbon","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"5","key":"zoi260131r1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"21","key":"zoi260131r2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","article-title":"Results of initial low-dose computed tomographic screening for lung cancer.","volume":"368","author":"Church","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi260131r3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1056\/NEJMoa1208962","article-title":"Results of the two incidence screenings in the National Lung Screening Trial.","volume":"369","author":"Aberle","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi260131r4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial.","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260131r5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12890-019-0883-x","article-title":"Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis.","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"5","key":"zoi260131r6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"10","key":"zoi260131r7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"zoi260131r10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.7326\/0003-4819-159-6-201309170-00690","article-title":"Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.","volume":"159","author":"Humphrey","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi260131r11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3322\/caac.21811","article-title":"Screening for lung cancer: 2023 guideline update from the American Cancer Society.","volume":"74","author":"Wolf","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"zoi260131r12","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1200\/JCO.21.02496","article-title":"Lung cancer diagnosed through screening, lung nodule, and neither program: a prospective observational study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta cohort.","volume":"40","author":"Osarogiagbon","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi260131r13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jtho.2025.01.024","article-title":"Barriers to lung cancer screening in a multi-disciplinary thoracic oncology program cohort: effects of an incidental pulmonary nodule program.","volume":"20","author":"Liao","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"2","key":"zoi260131r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0787","article-title":"Evaluation of lung cancer risk among persons undergoing screening or guideline-concordant monitoring of lung nodules in the Mississippi Delta.","volume":"6","author":"Osarogiagbon","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi260131r15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jtho.2023.11.015","article-title":"Incidentally detected lung cancer in persons too young or too old for lung cancer screening in a Mississippi Delta Cohort.","volume":"19","author":"Liao","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"1","key":"zoi260131r16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025.","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"zoi260131r17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12931-025-03344-0","article-title":"Regional trends and disparities of lung cancer mortality in the United States, 1999-2022: a retrospective cohort study.","volume":"26","author":"Billion","year":"2025","journal-title":"Respir Res"},{"issue":"4","key":"zoi260131r19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi260131r21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.chest.2021.07.2168","article-title":"The probability of lung cancer in patients with incidentally detected pulmonary nodules: clinical characteristics and accuracy of prediction models.","volume":"161","author":"Vachani","year":"2022","journal-title":"Chest"},{"issue":"10","key":"zoi260131r22","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.jtho.2019.05.044","article-title":"Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial.","volume":"14","author":"National Lung Screening Trial Research Team","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"1","key":"zoi260131r23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35676","article-title":"The 2021 US Preventive Services Task Force lung cancer screening eligibility criteria disproportionately exclude younger Black patients with lung cancer.","volume":"131","author":"Potter","year":"2025","journal-title":"Cancer"},{"issue":"11","key":"zoi260131r24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.46222","article-title":"Age-based screening for lung cancer surveillance in the US.","volume":"8","author":"Yang","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi260131r25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.7326\/M14-2086","article-title":"Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.","volume":"162","author":"Pinsky","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi260131r27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacr.2023.09.009","article-title":"ACR Lung-RADS v2022: assessment categories and management recommendations.","volume":"21","author":"Christensen","year":"2024","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"zoi260131r28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/RTI.0000000000000768","article-title":"Risk and time to diagnosis of lung cancer in incidental pulmonary nodules.","volume":"39","author":"Hammer","year":"2024","journal-title":"J Thorac Imaging"},{"key":"zoi260131r29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.lungcan.2022.07.017","article-title":"Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK.","volume":"171","author":"Robbins","year":"2022","journal-title":"Lung Cancer"},{"issue":"2","key":"zoi260131r30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jtho.2022.09.220","article-title":"Potential impact of criteria modifications on race and sex disparities in eligibility for lung cancer screening.","volume":"18","author":"Smeltzer","year":"2023","journal-title":"J Thorac Oncol"},{"issue":"1","key":"zoi260131r31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S1470-2045(21)00590-8","article-title":"USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.","volume":"23","author":"Tammem\u00e4gi","year":"2022","journal-title":"Lancet Oncol"},{"issue":"1","key":"zoi260131r32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.chest.2021.06.066","article-title":"Addressing sex disparities in lung cancer screening eligibility: USPSTF vs PLCOm2012 criteria.","volume":"161","author":"Pasquinelli","year":"2022","journal-title":"Chest"},{"issue":"1","key":"zoi260131r33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jtho.2021.09.011","article-title":"Impact of joint lung cancer screening and cessation interventions under the new recommendations of the U.S. Preventive Services Task Force.","volume":"17","author":"Meza","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"21","key":"zoi260131r34","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.3390\/jcm14217812","article-title":"Early detection of lung cancer: a review of innovative milestones and techniques.","volume":"14","author":"Habbab","year":"2025","journal-title":"J Clin Med"},{"key":"zoi260131r35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.lungcan.2022.12.002","article-title":"Diagnostic test accuracy of artificial intelligence-based imaging for lung cancer screening: a systematic review and meta-analysis.","volume":"176","author":"Thong","year":"2023","journal-title":"Lung Cancer"},{"key":"zoi260131r20","volume-title":"Lung-RADS Version 1.1 Assessment Categories","author":"American College of Radiology","year":"2019"},{"key":"zoi260131r26","volume-title":"Lung-RADS Version 1.0 Assessment Categories","author":"American College of Radiology","year":"2014"},{"key":"zoi260131r8","unstructured":"National Coverage Analysis (NCA) Decision Memo: Screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). Centers for Medicare & Medicaid Services. 2015. Accessed June 16, 2025. https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncacal-decision-memo.aspx?proposed=N&NCAId=274"},{"key":"zoi260131r9","unstructured":"National Coverage Determination (NCD): Lung cancer screening with low dose computed tomography (LDCT) (210.14). Centers for Medicare & Medicaid Services. February 10, 2022. Accessed June 16, 2025. https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncd.aspx?NCIDid=364"},{"key":"zoi260131r18","unstructured":"Delta Regional Authority. Accessed June 16, 2025. https:\/\/dra.gov"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2847680\/liao_2026_oi_260131_1775496098.42342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:30:30Z","timestamp":1776094230000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2847680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.3171","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}